{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:44:16Z","timestamp":1787510656981,"version":"build-2736575974"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ecco-jccjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.crohns.2013.03.005","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T10:50:04Z","timestamp":1365245404000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Topical therapy is underused in patients with ulcerative colitis"],"prefix":"10.1093","volume":"8","author":[{"given":"F.","family":"Seibold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Beglinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mottet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Pittet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"issue":"4","key":"10.1016\/j.crohns.2013.03.005_bb0005","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","article-title":"Clinical course during the first 10years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)","volume":"44","author":"Solberg","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl. 4","key":"10.1016\/j.crohns.2013.03.005_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2036.16.s4.3.x","article-title":"Review article: treatment of mild to moderate ulcerative colitis and pouchitis","volume":"16","author":"Gionchetti","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.crohns.2013.03.005_bb0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.40.6.775","article-title":"Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis","volume":"40","author":"Marshall","year":"1997","journal-title":"Gut"},{"issue":"12 Suppl.","key":"10.1016\/j.crohns.2013.03.005_bb0020","doi-asserted-by":"crossref","first-page":"67S","DOI":"10.1007\/BF01312467","article-title":"Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis","volume":"32","author":"Campieri","year":"1987","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.crohns.2013.03.005_bb0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2036.1995.tb00384.x","article-title":"Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis","volume":"9","author":"Marshall","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.crohns.2013.03.005_bb0030","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00004836-198808000-00012","article-title":"5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis?","volume":"10","author":"Campieri","year":"1988","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"10.1016\/j.crohns.2013.03.005_bb0035","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.mib.0000231495.92013.5e","article-title":"Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials","volume":"12","author":"Regueiro","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.crohns.2013.03.005_bb0040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis: current management","volume":"6","author":"Dignass","year":"2012","journal-title":"J Crohns Colitis"},{"issue":"2 Suppl. 3","key":"10.1016\/j.crohns.2013.03.005_bb0045","first-page":"1","article-title":"5-ASA dose\u2013response: maximizing efficacy and adherence","volume":"6","author":"Katz","year":"2010","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.crohns.2013.03.005_bb0050","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.3748\/wjg.15.4353","article-title":"5-ASA in ulcerative colitis: improving treatment compliance","volume":"15","author":"Prantera","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.crohns.2013.03.005_bb0055","first-page":"s2","article-title":"The challenge of compliance and persistence: focus on ulcerative colitis","volume":"14","author":"Kane","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.crohns.2013.03.005_bb0060","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2165\/00003495-200868080-00006","article-title":"Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes","volume":"68","author":"Fernandez-Becker","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.crohns.2013.03.005_bb0065","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1365-2036.2008.03698.x","article-title":"Review article: medication non-adherence in ulcerative colitis\u2014strategies to improve adherence with mesalazine and other maintenance therapies","volume":"27","author":"Hawthorne","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2013.03.005_bb0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2036.2006.02809.x","article-title":"Systematic review: adherence issues in the treatment of ulcerative colitis","volume":"23","author":"Kane","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2013.03.005_bb0075","first-page":"CD004115","article-title":"Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"1","author":"Marshall","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.crohns.2013.03.005_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1445-5994.2007.01601.x","article-title":"Management of distal ulcerative colitis: frequently asked questions analysis","volume":"38","author":"James","year":"2008","journal-title":"Intern Med J"},{"key":"10.1016\/j.crohns.2013.03.005_bb0085","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1111\/j.1572-0241.2008.02152.x","article-title":"Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis","volume":"103","author":"Cortot","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2013.03.005_bb0090","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1365-2036.2000.00784.x","article-title":"Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study","volume":"14","author":"Pokrotnieks","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2013.03.005_bb0095","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/BF01308084","article-title":"Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis","volume":"37","author":"Campieri","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.crohns.2013.03.005_bb0100","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1365-2036.2007.03468.x","article-title":"Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis","volume":"26","author":"Eliakim","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2013.03.005_bb0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00042737-199606000-00010","article-title":"Beclomethasone dipropionate (3mg) versus 5-aminosalicylic acid (2g) versus the combination of both (3mg\/2 g) as retention enemas in active ulcerative proctitis","volume":"8","author":"Mulder","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2013.03.005_bb0110","first-page":"1867","article-title":"A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis","volume":"92","author":"Safdi","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2013.03.005_bb0115","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/j.1572-0241.2000.02180.x","article-title":"Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis","volume":"95","author":"Marshall","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2013.03.005_bb0120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1159\/000233295","article-title":"Medical management of ulcerative colitis","volume":"27","author":"Rogler","year":"2009","journal-title":"Dig Dis"},{"key":"10.1016\/j.crohns.2013.03.005_bb0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.crohns.2007.11.002","article-title":"European evidence-based consensus on the management of ulcerative colitis: current management","volume":"2","author":"Travis","year":"2008","journal-title":"Crohns Colitis"},{"key":"10.1016\/j.crohns.2013.03.005_bb0130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1517\/14656566.9.5.741","article-title":"Ulcerative proctitis: a review of pharmacotherapy and management","volume":"9","author":"Lakatos","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.crohns.2013.03.005_bb0135","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1572-0241.2005.40849.x","article-title":"Are patients with inflammatory bowel disease receiving optimal care?","volume":"100","author":"Reddy","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2013.03.005_bb0140","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ije\/dyn180","article-title":"Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study","volume":"38","author":"Pittet","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.crohns.2013.03.005_bb0145","first-page":"2343","article-title":"Practicality of 5-aminosalicylic suppositories for long-term treatment of inactive distal ulcerative colitis","volume":"46","author":"Casellas","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.crohns.2013.03.005_bb0150","first-page":"1079","article-title":"5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial","volume":"85","author":"D'Arienzo","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2013.03.005_bb0155","first-page":"1143","article-title":"Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study","volume":"92","author":"D'Albasio","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2013.03.005_bb0160","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/00365520310008133","article-title":"Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis","volume":"39","author":"Piodi","year":"2004","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.crohns.2013.03.005_bb0165","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2036.2010.04354.x","article-title":"Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis","volume":"32","author":"Hartmann","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2013.03.005_bb0170","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/gut.2004.060103","article-title":"Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild\/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study","volume":"54","author":"Marteau","year":"2005","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.crohns.2013.03.005_bb0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.crohns.2009.09.007","article-title":"Clinical trial: preliminary efficacy and safety study of a new Budesonide-MMX\u00ae 9mg extended-release tablets in patients with active left-sided ulcerative colitis","volume":"4","author":"D'Haens","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.crohns.2013.03.005_bb0180","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cgh.2011.10.043","article-title":"Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis","volume":"10","author":"Ford","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.crohns.2013.03.005_bb0185","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/ibd.21607","article-title":"Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002\u20132006","volume":"17","author":"Lakatos","year":"2011","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613001098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613001098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/8\/1\/56\/5154844\/8-1-56.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T01:41:47Z","timestamp":1503538907000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2013.03.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1873994613001098"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2013.03.005","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical therapy is underused in patients with ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Crohn's and Colitis","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.crohns.2013.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}